IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 48 filers reported holding IBERE PHARMACEUTICALS in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $759,232 | +1.8% | 75,246 | 0.0% | 0.02% | 0.0% |
| Q3 2022 | $746,000 | +1.1% | 75,246 | 0.0% | 0.02% | -8.7% |
| Q2 2022 | $738,000 | 0.0% | 75,246 | 0.0% | 0.02% | +53.3% |
| Q1 2022 | $738,000 | -6.6% | 75,246 | -7.4% | 0.02% | -6.2% |
| Q4 2021 | $790,000 | +8.7% | 81,246 | +8.3% | 0.02% | +6.7% |
| Q3 2021 | $727,000 | +0.3% | 75,000 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $725,000 | – | 75,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |